Compliance documents describe what should happen. Regulators and auditors measure what actually did. Shrink Manager® operates at the execution layer between them — generating audit-verifiable records as a structured byproduct of daily work rather than a separate documentation burden.
Most compliance software operates at the documentation layer: defining what should happen, producing policy documents, and generating evidence after the fact. Most ERPs operate at the planning layer: coordinating resources, recording transactions, producing reports.
Regulators and buyers increasingly audit the execution layer — the work that actually happens between plan and record. Shrink Manager is purpose-built for that layer. It enforces workflow, gates artifact creation behind verified execution, and generates compliance evidence as a structured byproduct.
These are operational patterns covered across the twelve U.S. patent applications. The architecture is domain-general; which patterns are configured in a given deployment depends on the operation. Channel partners add the vertical expertise.
Shrink Manager was built for and validated in regulated food manufacturing. The underlying architecture is domain-general and applies to any industry where execution must be audit-verifiable, time-stamped, and independently corroborated. The following are target verticals where the Company is actively scoping application with channel and industry partners.
Customs documentation, export licensing, sanctions and denied-party screening, and cross-border compliance records. The execution-layer architecture aligns naturally with trade compliance obligations where every transaction must be verifiable and every record must match the physical movement of goods.
Batch records, GMP documentation, serialization, and chain-of-custody for active pharmaceutical ingredient (API) and finished-product manufacturing. Temporal authenticity and dual-source verification are relevant to FDA 21 CFR Part 11 electronic records requirements; fit is being scoped with partners.
Design history files, device master records, and production records under FDA 21 CFR Part 820 and ISO 13485. Workflow-gated execution and execution-verified artifacts are expected to carry over to medical device manufacturing; fit is being scoped with partners.
Industries with documented chain-of-custody, time-stamped execution requirements, or third-party attestation obligations are candidates for application. Laboratory quality control, clinical documentation, and financial transaction reconciliation have been preliminarily identified.
Shrink Software has twelve U.S. non-provisional patent applications pending across the execution-control architecture. The portfolio covers foundational workflow control, adjacent commercial workflows, production-anchored execution, and closed-loop capture and adjust. Together, the applications address multiple aspects of the platform rather than a single point feature.
The execution-control patterns behind these applications are not theoretical. They were developed inside a real multi-site regulated production operation — Anu Sushi LLC, an affiliated operator — refined across 1M+ units annually, and validated against institutional buyer audits and FSMA 204 requirements. The architecture's maturity in food is the foundation for its application to adjacent regulated industries.
Shrink Software is actively scoping application of the execution-control architecture with channel and industry partners in regulated operations beyond food. Initial conversations are exploratory — we bring the architecture and the patent portfolio; you bring domain expertise and buyer relationships.
Questions? Email hello@shrinksoftware.com · Channel partners welcome